Pathology and Molecular Genetics of Pancreatic Neoplasms

Hyaline Globules in Neuroendocrine and Solid-pseudopapillary Neoplasms of the Pancreas

(2011) Zina Meriden et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Regulatory Mechanisms of Tumor Suppressor P16INK4Aand Their Relevance to Cancer

(2011) Junan Li et al.   BIOCHEMISTRY

Genome profiling of pancreatic adenocarcinoma

(2011) David J. Birnbaum et al.   GENES CHROMOSOMES & CANCER

High-Throughput Mutation Profiling in Intraductal Papillary Mucinous Neoplasm (IPMN)

(2011) Nir Lubezky et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Analysis of LKB1 mutations and other molecular alterations in pancreatic acinar cell carcinoma

(2011) Roeland F de Wilde et al.   MODERN PATHOLOGY

Everolimus for Advanced Pancreatic Neuroendocrine Tumors

(2011) James C. Yao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Elevated microRNA miR-21 Levels in Pancreatic Cyst Fluid Are Predictive of Mucinous Precursor Lesions of Ductal Adenocarcinoma

(2011) Ji Kon Ryu et al.   PANCREATOLOGY

Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways

(2011) J. Wu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Altered Telomeres in Tumors with ATRX and DAXX Mutations

(2011) C. M. Heaphy et al.   SCIENCE

DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors

(2011) Y. Jiao et al.   SCIENCE

Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development

(2011) J. Wu et al.   Science Translational Medicine

Copy number alterations in pancreatic cancer identify recurrentPAK4amplification

(2010) Shuaili Chen et al.   CANCER BIOLOGY & THERAPY

KRAS and BRAF: drug targets and predictive biomarkers

(2010) Efsevia Vakiani et al.   JOURNAL OF PATHOLOGY

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

(2010) Shinichi Yachida et al.   NATURE

E-cadherin/Catenin Complex Status in Solid Pseudopapillary Tumor of the Pancreas

(2009) Mona A. El-Bahrawy et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer

(2009) A. Blackford et al.   CLINICAL CANCER RESEARCH

VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors

(2009) A M Schmitt et al.   ENDOCRINE-RELATED CANCER

Fluorescence In Situ Hybridization to Visualize Genetic Abnormalities in Interphase Cells of Acinar Cell Carcinoma, Ductal Adenocarcinoma, and Islet Cell Carcinoma of the Pancreas

(2009) Gordon W. Dewald et al.   MAYO CLINIC PROCEEDINGS

Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma

(2009) Jonathan R Brody et al.   MODERN PATHOLOGY

KRAS2 Mutations in Human Pancreatic Acinar-Ductal Metaplastic Lesions Are Limited to Those with PanIN: Implications for the Human Pancreatic Cancer Cell of Origin

(2009) C. Shi et al.   MOLECULAR CANCER RESEARCH

Mutational Analyses of Multiple Oncogenic Pathways in Intraductal Papillary Mucinous Neoplasms of the Pancreas

(2009) Frank Schönleben et al.   PANCREAS

Impaired E-Cadherin Expression and Glutamine Synthetase Overexpression in Solid Pseudopapillary Neoplasm of the Pancreas

(2009) Virginie Audard et al.   PANCREAS

Pancreatic Cancer

(2008) Anirban Maitra et al.   Annual Review of Pathology-Mechanisms of Disease

Adverse prognosis of epigenetic inactivation in RUNX3 gene at 1p36 in human pancreatic cancer

(2008) S Nomoto et al.   BRITISH JOURNAL OF CANCER

Absence of E-Cadherin Expression Distinguishes Noncohesive from Cohesive Pancreatic Cancer

(2008) J. M. Winter et al.   CLINICAL CANCER RESEARCH

Membrane loss and aberrant nuclear localization of E-cadherin are consistent features of solid pseudopapillary tumour of the pancreas. An immunohistochemical study using two antibodies recognizing different domains of the E-cadherin molecule

(2008) R Chetty et al.   HISTOPATHOLOGY

MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival

(2008) Mary Dillhoff et al.   JOURNAL OF GASTROINTESTINAL SURGERY

PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas

(2008) Frank Schönleben et al.   LANGENBECKS ARCHIVES OF SURGERY

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

(2008) S. Jones et al.   SCIENCE

Genomic Profiling Identifies GATA6 as a Candidate Oncogene Amplified in Pancreatobiliary Cancer

(2008) Kevin A. Kwei et al.   PLoS Genetics

Histologic, Immunohistochemical, and Molecular Classification of 52 IPMNs of the Pancreas

(2008) Barbara Chadwick et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Loss of the eukaryotic initiation factor 3f in pancreatic cancer

(2007) Adriana Doldan et al.   MOLECULAR CARCINOGENESIS